Teriparatide clinical trials
Also written Forteo, Forsteo, LY333334 and EBP05.
Includes 1 study of RGB-10.
How each study uses Teriparatide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Teriparatide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Nov 2002 · FORTEO · NDA 021318 (FDA, Drugs@FDA)
- European Union
- 10 Jun 2003 · Forsteo · EMEA/H/C/000425 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Synthetic Human Parathyroid Hormone 1-34
- 2
Biosimilars
- Terrosa
- 1
Studies by the year they started
118 studies that test it; most in 2012 (11); 1 more planned to start later
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1996 | 1 |
| 1999 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 8 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 7 |
| 2007 | 5 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 7 |
| 2012 | 11 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 49 · Other 73
Eli Lilly and Company (33) · Massachusetts General Hospital (7) · Entera Bio Ltd. (5) · Medical University of Vienna (4) · University Hospital, Linkoeping (3) · Thomas J. Schnitzer (2) · Post Graduate Institute of Medical Education and Research, Chandigarh (2) · Columbia University (2)
Often tested with
Tested in the same studies.
Alendronate (7) · Denosumab (5) · Raloxifene (5) · Zoledronic Acid (3) · Parathyroid Hormone (3) · Calcium (2) · Cinacalcet (1) · Calcitriol (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Teriparatide.
- Dec 2026Fracture Recovery for Returning to Duty (Teriparatide STRONG)Phase 4 · University of South Carolina
- Jan 2027Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverPhase 4 · Madhumathi Rao
- Nov 2027Combined Anabolic TherapyPhase 4 · Massachusetts General Hospital
Studies
Open first, then newest update. How each study uses Teriparatide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 122
- Combined Anabolic TherapyRecruitingPhase 4Massachusetts General HospitalNCT06558188Written as Teriparatide
- PROactive HEALing in High-Risk Pelvic and Non-hip Lower Extremity Fragility Fractures (PRO HEAL Pilot)Not yet recruitingPhase 1/2University of CalgaryNCT06303284Written as subcutaneous Teriparatide injection
- A Study of B-3E07 and Forsteo® in Healthy Adult Female ParticipantsRecruitingPhase 1Syneos HealthNCT07497503Written as Forsteo®
- Precision Medicine Approach for Osteoporosis - Follow Up StudyEnrolling by invitationPhase 4Paul F NetzelNCT06264609Written as Teriparatide
- Study of the Key Techniques of Prevention and Treatment of Osteoporotic RefractureRecruitingNot applicablePeking Union Medical College HospitalNCT05866029Written as Teriparatide
- Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney DiseaseRecruitingPhase 4Ditte HansenNCT04522622Written as Teriparatide
- Teriparatide on Maxillary Sinus Floor OsseointegrationRecruitingPhase 4Universidad de ValparaisoNCT06061354Written as Teriparatide
- Fracture Recovery for Returning to Duty (Teriparatide STRONG)Enrolling by invitationPhase 4University of South CarolinaNCT04589819Written as Teriparatide
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisCompletedNot applicableKhyber Medical University PeshawarNCT07242612Written as Teriparatide
- Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic AcidCompletedPhase 4University of EdinburghNCT03735537Written as Teriparatide Pen Injector
- Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of ActionCompletedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT01293292Written as Teriparatide
- Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion SurgeryActive, not recruitingNot applicableThe University of Hong KongNCT03770338Written as Teriparatide
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverActive, not recruitingPhase 4Madhumathi RaoNCT05151484Written as Teriparatide
- Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous ForteoCompletedPhase 1Entera Bio Ltd.NCT05965167Written as EBP05
- Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord InjuryCompletedPhase 2Thomas J. SchnitzerNCT01225055Written as Teriparatide
- Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and AgingTerminatedNot applicableUniversity of Milano BicoccaNCT04669782Written as Teriparatide
- The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNACompletedPhase 3King Chulalongkorn Memorial HospitalNCT03133195Written as Teriparatide
- Bone Modeling Effects of Combined Anabolic/Antiresorptive AdministrationCompletedPhase 4Massachusetts General HospitalNCT04026256Written as Teriparatide
- Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur FracturesCompletedPhase 3University Health Network, TorontoNCT01896011Written as Teriparatide 20 mcg
- Teriparatide as a Chondroregenerative Therapy in OACompletedPhase 2Christopher RitchlinNCT03072147Written as Teriparatide
See all 122 studies that test Teriparatide →
Given beside what is tested · 7 — Teriparatide is usual care or a partner of the new treatment
- Novel Combination Therapy for Osteoporosis in MenCompletedPhase 4VA Office of Research and DevelopmentNCT03994172Written as Teriparatide or human parathyroid hormone (PTH) 1-34
- Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression FractureStatus unknownPhase 2Inbo HanNCT05018637Written as Teriparatide
- Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese AdultsCompletedPhase 1Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT04747392Written as FORSTEO
- PTH and Vibration in OSteoporosis StudyCompletedNot applicableOdense University HospitalNCT02563353Written as teriparatide
- Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone ResorptionCompletedPhase 4Massachusetts General HospitalNCT01750086Written as Teriparatide 40-mcg subcutaneous injection
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?CompletedPhase 4University of Wisconsin, MadisonNCT01166958Written as Teriparatide
- A Study of Teriparatide in Japanese Osteoporosis PatientsCompletedPhase 4Eli Lilly and CompanyNCT01430104Written as Teriparatide
As the comparator · 13 — what is tested is compared with Teriparatide
- To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FractureNot yet recruitingPhase 3Qilu Pharmaceutical Co., Ltd.NCT06898060Written as Teriparatide Injection
- An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCompletedPhase 3AmgenNCT01796301Written as Teriparatide
- Study Evaluating PK of PTH Administered Orally Via RaniPill™ CapsuleCompletedPhase 1RANI TherapeuticsNCT05164614Written as Forteo
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCompletedPhase 2AmgenNCT00896532Written as Teriparatide
- G56W1 in Women With Postmenopausal OsteoporosisStatus unknownPhase 1/2Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT03720886Written as teriparatide acetate(Teribone™)
- A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.TerminatedPhase 2GlaxoSmithKlineNCT00471237Written as Teriparatide
- Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 2Radius Health, Inc.NCT00542425Written as teriparatide
- Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal WomenCompletedPhase 3Radius Health, Inc.NCT01343004Written as teriparatide
- A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo PenCompletedPhase 1Zosano Pharma CorporationNCT02478879Written as FORTEO
- Comparison Study of PTHrP and PTH to Treat OsteoporosisCompletedPhase 2University of PittsburghNCT00853723Written as Parathyroid hormone (1-34)
- Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal WomenCompletedPhase 2Unigene Laboratories Inc.NCT01321723Written as Forsteo (Teriparatide)
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal WomenCompletedPhase 1NovartisNCT01224717Written as Forsteo
- Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With OsteoporosisCompletedPhase 3NovartisNCT00439244Written as Teriparatide
Codes
What other systems call Teriparatide · ClinicalTrials.gg INT008698
- MeSH (NLM) D019379TeriparatideConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 10T9CSU89ITERIPARATIDEConfirmed FDA, NLM
- RxNorm 32915One source FDA
- NCI Thesaurus C61966TeriparatideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019379 | Teriparatide | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 10T9CSU89I | TERIPARATIDE | Confirmed FDA, NLM |
| RxNorm | 32915 | — | One source FDA |
| NCI Thesaurus | C61966 | Teriparatide | One source FDA |
Also registered as teriparatide acetate (UNII 9959P4V12N · RxNorm 114260).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.